Avaí Bio and Austrianova have completed a Master Cell Bank of genetically modified cells overexpressing the α-Klotho protein, a key anti-aging factor, marking a major step toward clinical trials for cell-based therapies targeting aging and related diseases. This milestone supports the development of treatments for conditions like kidney disease, neurodegenerative disorders, and vascular diseases by restoring the 'longevity protein.' The global cell therapy market is expected to grow significantly, driven by advances in regenerative medicine and increasing demand for longevity and neurodegenerative disease treatments. Other biotech companies like Geron, BioAge Labs, Lineage Cell Therapeutics, and Fate Therapeutics are also progressing in clinical studies for therapies addressing blood cancer, inflammation, macular degeneration, and lupus nephritis, highlighting broad innovation in cell and gene therapies.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
Ethereum's price rose about 11% over the past week to around $1,920, outperforming major cryptocurrencies like Bitcoin and Solana. This rally is fueled by $96 million inflows into U.S. spot Ether ETFs early in the week, with BlackRock's ETHA product ...
The XRP Ledger has surpassed 8 million activated accounts, marking steady growth since March 2026. However, daily active addresses have declined to a 2026 low of 25,350, indicating less frequent user engagement despite overall adoption. XRP's price f...
